X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (297003) 297003
Magazine Article (1023) 1023
Patent (791) 791
Book Chapter (281) 281
Book / eBook (161) 161
Newsletter (97) 97
Conference Proceeding (95) 95
Publication (89) 89
Web Resource (64) 64
Dissertation (60) 60
Reference (25) 25
Book Review (23) 23
Government Document (10) 10
Newspaper Article (10) 10
Streaming Video (8) 8
Trade Publication Article (2) 2
Journal / eJournal (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (282002) 282002
female (172166) 172166
combined modality therapy (161490) 161490
male (150194) 150194
middle aged (127185) 127185
adult (111655) 111655
antineoplastic combined chemotherapy protocols - therapeutic use (106145) 106145
aged (98568) 98568
oncology (87054) 87054
treatment outcome (68386) 68386
chemotherapy (48638) 48638
cancer (41159) 41159
prognosis (40024) 40024
adolescent (35109) 35109
follow-up studies (33530) 33530
neoplasm staging (32921) 32921
retrospective studies (31248) 31248
surgery (31010) 31010
antineoplastic combined chemotherapy protocols - adverse effects (30818) 30818
aged, 80 and over (29588) 29588
survival rate (26237) 26237
child (25447) 25447
care and treatment (23364) 23364
therapy (23228) 23228
animals (23062) 23062
antineoplastic combined chemotherapy protocols - administration & dosage (21698) 21698
radiotherapy (21627) 21627
hematology (20818) 20818
cisplatin - administration & dosage (20574) 20574
disease-free survival (19365) 19365
survival analysis (19114) 19114
survival (18425) 18425
time factors (17038) 17038
antineoplastic agents - therapeutic use (16258) 16258
fluorouracil - administration & dosage (16220) 16220
chemotherapy, adjuvant (15833) 15833
child, preschool (15777) 15777
medicine & public health (15627) 15627
breast neoplasms - drug therapy (14991) 14991
doxorubicin - administration & dosage (14721) 14721
risk factors (14573) 14573
drug administration schedule (14555) 14555
cyclophosphamide - administration & dosage (14487) 14487
prospective studies (14361) 14361
carcinoma (13994) 13994
lung neoplasms - drug therapy (13973) 13973
young adult (13765) 13765
remission induction (13243) 13243
research (12722) 12722
recurrence (12680) 12680
cisplatin (12634) 12634
analysis (12402) 12402
mice (12307) 12307
tumors (11665) 11665
trial (11536) 11536
health aspects (11449) 11449
infant (11015) 11015
breast neoplasms - pathology (10562) 10562
clinical trials as topic (10281) 10281
breast cancer (10153) 10153
vincristine - administration & dosage (10141) 10141
management (9989) 9989
tomography, x-ray computed (9962) 9962
medicine, general & internal (9597) 9597
dose-response relationship, drug (9501) 9501
neoplasm metastasis (9440) 9440
radiotherapy dosage (9405) 9405
metastasis (9318) 9318
hematology, oncology and palliative medicine (9284) 9284
pharmacology & pharmacy (9048) 9048
radiology, nuclear medicine & medical imaging (9030) 9030
lymphatic metastasis (8744) 8744
pediatrics (8729) 8729
drug therapy (8468) 8468
radiation-therapy (8403) 8403
abridged index medicus (8219) 8219
deoxycytidine - analogs & derivatives (8219) 8219
etoposide - administration & dosage (8135) 8135
antineoplastic agents - administration & dosage (8053) 8053
combined modality therapy - methods (8046) 8046
diagnosis (8046) 8046
adenocarcinoma - drug therapy (8022) 8022
disease progression (7954) 7954
carcinoma, non-small-cell lung - drug therapy (7888) 7888
randomized controlled trials as topic (7858) 7858
children (7823) 7823
patients (7796) 7796
paclitaxel - administration & dosage (7665) 7665
lung neoplasms - pathology (7640) 7640
cell line, tumor (7551) 7551
quality of life (7505) 7505
clinical trials (7437) 7437
clinical neurology (7350) 7350
expression (7311) 7311
diagnosis, differential (7267) 7267
neoadjuvant therapy (7228) 7228
neoplasm recurrence, local (7142) 7142
antineoplastic combined chemotherapy protocols - pharmacology (7122) 7122
combination (7112) 7112
risk assessment (7066) 7066
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (85) 85
Online Resources - Online (63) 63
Collection Dvlpm't (Acquisitions) - Vendor file (20) 20
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (11) 11
Robarts - Stacks (6) 6
UofT at Mississauga - Stacks (5) 5
Collection Dvlpm't (Acquisitions) - Closed Orders (4) 4
OISE - Stacks (3) 3
Lakeridge Health Sciences - Online (2) 2
Scarborough Hospital - Online (2) 2
UTL at Downsview - May be requested (2) 2
Baycrest Hospital - Stacks (1) 1
Credit Valley Hospital - Online (1) 1
Criminology - Stacks (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
Knox College (Caven) - Stacks (1) 1
Providence Healthcare - Reference (1) 1
Providence Healthcare - Stacks (1) 1
Scarborough Hospital - Birchmount (1) 1
Scarborough Hospital - General (1) 1
Scarborough Hospital - Sunnybrook Stacks (1) 1
Stacks (1) 1
Sunnybrook Health Sciences Centre - Oshawa (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (251825) 251825
German (15898) 15898
Japanese (13424) 13424
Russian (9420) 9420
French (7011) 7011
Chinese (4523) 4523
Spanish (3654) 3654
Italian (1899) 1899
Polish (1289) 1289
Dutch (605) 605
Portuguese (532) 532
Hungarian (419) 419
Ukrainian (311) 311
Czech (306) 306
Romanian (285) 285
Bulgarian (256) 256
Finnish (228) 228
Danish (205) 205
Hebrew (157) 157
Korean (153) 153
Norwegian (129) 129
Turkish (105) 105
Serbian (80) 80
Swedish (78) 78
Croatian (68) 68
Slovak (43) 43
Lithuanian (25) 25
Icelandic (11) 11
Bosnian (6) 6
Afrikaans (5) 5
Greek (5) 5
Persian (5) 5
Belarusian (2) 2
Slovenian (2) 2
Arabic (1) 1
Azerbaijani (1) 1
Thai (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2017, Volume 377, Issue 4, pp. 338 - 351
Journal Article
European Archives of Oto-Rhino-Laryngology, ISSN 0937-4477, 1/2005, Volume 262, Issue 1, pp. 1 - 7
...) with concomitant accelerated uninterrupted radiotherapy (RT). Twenty-three patients (median age: 54 years, range: 35–70) with locally advanced squamous cell carcinoma of the head and neck... 
Medicine | Base of the tongue | Head and neck cancer | Organ preservation | Chemoradiotherapy | Amifostine | head and neck cancer | base of the tongue | CONVENTIONAL RADIOTHERAPY | chemoradiotherapy | ACCELERATED RADIOTHERAPY | STAGE-III | RADIATION-THERAPY | ALTERNATING CHEMOTHERAPY | ONCOLOGY GROUP RTOG | III RANDOMIZED-TRIAL | OTORHINOLARYNGOLOGY | SQUAMOUS-CELL CARCINOMA | LOCALLY ADVANCED HEAD | amifostine | CONCURRENT CHEMORADIOTHERAPY | organ preservation | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Male | Esophageal Neoplasms - radiotherapy | Carcinoma, Squamous Cell - radiotherapy | Tongue Neoplasms - drug therapy | Esophageal Neoplasms - pathology | Nasopharyngeal Neoplasms - pathology | Nasopharyngeal Neoplasms - radiotherapy | Adult | Female | Nasopharyngeal Neoplasms - drug therapy | Tongue Neoplasms - radiotherapy | Radiotherapy Dosage | Drug Administration Schedule | Combined Modality Therapy | Tongue Neoplasms - pathology | Hypopharyngeal Neoplasms - radiotherapy | Carcinoma, Squamous Cell - drug therapy | Cisplatin - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Hypopharyngeal Neoplasms - pathology | Amifostine - therapeutic use | Aged | Hypopharyngeal Neoplasms - drug therapy | Neoplasm Staging | Esophageal Neoplasms - drug therapy
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2019, Volume 381, Issue 5, pp. 455 - 464
Journal Article
Annals of oncology, ISSN 0923-7534, 2015, Volume 26, Issue 8, pp. 1533 - 1546
The 14th St Gallen International Breast Cancer Conference (2015) reviewed substantial new evidence on locoregional and systemic therapies for early breast cancer... 
early breast cancer | systemic adjuvant therapies | St Gallen Consensus | radiation therapy | surgery | Radiation therapy | Early breast cancer | Systemic adjuvant therapies | Surgery | ADJUVANT CHEMOTHERAPY | ENDOCRINE THERAPY | PREMENOPAUSAL WOMEN | ESTROGEN-RECEPTOR | PATHOLOGICAL COMPLETE RESPONSE | TUMOR-INFILTRATING LYMPHOCYTES | OVARIAN-FUNCTION SUPPRESSION | NEOADJUVANT CHEMOTHERAPY | ONCOLOGY | SENTINEL NODE | CONTRALATERAL PROPHYLACTIC MASTECTOMY | Carcinoma, Lobular - pathology | Receptors, Estrogen - metabolism | Humans | Carcinoma, Intraductal, Noninfiltrating - metabolism | Mastectomy - methods | Receptor, ErbB-2 - metabolism | Tamoxifen - administration & dosage | Breast Neoplasms - metabolism | Receptors, Progesterone - metabolism | Breast Neoplasms - therapy | Anthracyclines - administration & dosage | Carcinoma, Lobular - therapy | Carcinoma, Intraductal, Noninfiltrating - therapy | Antineoplastic Agents, Hormonal - therapeutic use | Axilla | Carcinoma, Ductal, Breast - pathology | Female | Carcinoma, Ductal, Breast - metabolism | Mastectomy, Segmental - methods | Trastuzumab - administration & dosage | Carcinoma, Ductal, Breast - therapy | Taxoids - administration & dosage | Carcinoma, Intraductal, Noninfiltrating - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Chemotherapy, Adjuvant - methods | Radiotherapy, Adjuvant - methods | Carcinoma, Lobular - metabolism | Platinum Compounds - administration & dosage | Lymph Node Excision - methods | Neoplasm Staging | Practice Guidelines as Topic | Special
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2014, Volume 370, Issue 21, pp. 2002 - 2013
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e669S - e690S
Journal Article
The lancet oncology, ISSN 1470-2045, 2015, Volume 16, Issue 2, pp. 187 - 199
Summary Background We aimed to compare overall survival after standard-dose versus high-dose conformal radiotherapy with concurrent chemotherapy and the addition of cetuximab to concurrent... 
Hematology, Oncology and Palliative Medicine | ONCOLOGY | COMPETING RISK | CLINICAL-TRIALS | THERAPY ONCOLOGY GROUP | CHEMORADIATION | INDUCTION | CARCINOMA | CHEMOTHERAPY | RADIATION-THERAPY | Prognosis | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Carcinoma, Large Cell - mortality | Radiotherapy, Image-Guided | Chemoradiotherapy | Carcinoma, Large Cell - secondary | Neoplasm Metastasis | Antibodies, Monoclonal, Humanized - administration & dosage | Carcinoma, Non-Small-Cell Lung - secondary | Carcinoma, Squamous Cell - mortality | Aged, 80 and over | Adult | Female | Cetuximab | Paclitaxel - administration & dosage | Radiotherapy Dosage | Carboplatin - administration & dosage | Carcinoma, Squamous Cell - therapy | Survival Rate | Combined Modality Therapy | Lung Neoplasms - therapy | Carcinoma, Non-Small-Cell Lung - mortality | Adenocarcinoma - secondary | Carcinoma, Non-Small-Cell Lung - therapy | Adenocarcinoma - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Radiotherapy, Conformal | Carcinoma, Squamous Cell - secondary | Aged | Neoplasm Staging | Carcinoma, Large Cell - therapy | Adenocarcinoma - mortality | Antimitotic agents | Care and treatment | Chemotherapy | Dosage and administration | Lung cancer, Non-small cell | Antineoplastic agents | Radiotherapy | Cancer | Index Medicus
Journal Article
The lancet oncology, ISSN 1470-2045, 2016, Volume 17, Issue 6, pp. 747 - 756
Journal Article